"The US Food and Drug Administration (USFDA) has approved the abbreviated new drug application filed by Granules Pharmaceuticals, Inc, a wholly owned foreign subsidiary of Granules India Ltd, for Trospium Chloride extended-release capsules, 60 mg," the company said in a regulatory filing.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2KxCjg5
via IFTTT
0 comments:
Post a Comment